Metraipolis › archive › dc_df5f00f0e9ff

Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients — Europe PMC PMID:41853788

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41853788
DOI
10.1515/almed-2025-0144
License (as archived)
solo-consultazione
Archived
2026-11-06T19:16:15.359Z
SHA-256 of the archived text
45210a188d26626f95edea2a7115f366a4ec122ecd5e381700c45ef3885267f9
Stable URL of this page
https://metraipolis.com/documento/dc_df5f00f0e9ff

How to cite

Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients — Europe PMC PMID:41853788 — Europe PMC (en), https://europepmc.org/article/MED/41853788 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_df5f00f0e9ff (Metraipolis archive dc_df5f00f0e9ff, sha256 45210a188d26626f95edea2a7115f366a4ec122ecd5e381700c45ef3885267f9)
BibTeX
@misc{dcdf5f00f0e9ff,
  title = {Comparison of diagnostic performance of GAAD, GALAD, and ASAP scores for detecting hepatocellular carcinoma in advanced liver fibrosis patients — Europe PMC PMID:41853788},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41853788},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_df5f00f0e9ff; sha256 45210a188d26626f95edea2a7115f366a4ec122ecd5e381700c45ef3885267f9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41853788. Agents can read the archived copy with the MCP tool read_document.